Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market.
A recent report by Galen Growth shows that in 2019, the total funding deployed in health tech in Asia continued its momentum and closed at $5 billion across 340 deals.
Galen Growth Asia has released its Q3 2019 Asia Pac HealthTech, aka digital health, ecosystem key trends interim report, which provides a checkpoint to bridge our mid-year and full year rep
Galen Growth Asia CEO and founder Julien de Salaberry shares key trends and insights on the second largest and fastest growing digital health ecosystem in the world.
South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.